Update on Managers' Transactions at Orion Corporation
Orion Corporation has disclosed information in accordance with the Market Abuse Regulation (EU) No 596/2014, detailing transactions involving shares and related securities conducted by managers and their closely associated individuals.
Transaction Details
Notified individual: Niclas Lindstedt
Position: Other senior manager
Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Type of notification: Initial Notification
Reference number: 74920/9/8
Overview of the Transaction
Transaction date: August 20, 2024
Exchange venue: NASDAQ HELSINKI LTD (XHEL)
Type of instrument: Share
ISIN: FI0009014377
Transaction nature: Disposal
Details of the Transaction
1. Volume: 614, Unit price: 46.7 EUR
2. Volume: 521, Unit price: 46.7 EUR
3. Volume: 200, Unit price: 46.7 EUR
4. Volume: 200, Unit price: 46.7 EUR
5. Volume: 100, Unit price: 46.7 EUR
6. Volume: 125, Unit price: 46.7 EUR
7. Volume: 100, Unit price: 46.7 EUR
8. Volume: 125, Unit price: 46.7 EUR
9. Volume: 8, Unit price: 46.7 EUR
10. Volume: 5, Unit price: 46.7 EUR
11. Volume: 2, Unit price: 46.7 EUR
Total transaction volume: 2000
Volume weighted average price: 46.7 EUR
About Orion Corporation
Orion is a Finnish pharmaceutical company with a global presence, dedicated to enhancing well-being for more than a century. The company is involved in the development, manufacturing, and marketing of both human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients. Orion boasts a diverse portfolio that includes proprietary and generic medicines, along with consumer health products. The company’s pharmaceutical research and development primarily targets key therapeutic areas such as oncology and pain management. Orion's proprietary products are used to treat various conditions, including cancer, neurological disorders, and respiratory issues. In the previous financial year, Orion reported net sales of EUR 1,190 million and had a workforce of approximately 3,600 employees. The company's A and B shares are traded on Nasdaq Helsinki.
Frequently Asked Questions
What is the nature of the transaction disclosed?
The transaction involves the disposal of shares by Niclas Lindstedt, who serves as a senior manager at Orion Corporation.
How many shares were disposed of?
A total of 2000 shares were disposed of, with an average price of 46.7 EUR per share.
What is Orion Corporation known for?
Orion Corporation specializes in the development, manufacturing, and marketing of human and veterinary pharmaceuticals, with a strong focus on oncology and pain management.
Where are Orion's shares listed?
The A and B shares of Orion Corporation are listed on Nasdaq Helsinki.
What was Orion's net sales figure in 2023?
In the last financial year, Orion's net sales reached EUR 1,190 million.